Dual Vaccine Against Influenza and Alzheimer's Disease
Author Information
Author(s): Hayk Davtyan, Anahit Ghochikyan, Richard Cadagan, Dmitriy Zamarin, Irina Petrushina, Nina Movsesyan, Luis Martinez-Sobrido, Randy A Albrecht, Adolfo García-Sastre, Michael G Agadjanyan
Primary Institution: Institute for Molecular Medicine, Huntington Beach, CA, USA
Hypothesis
In elderly people with pre-existing memory Th cells specific to influenza, this dual vaccine will simultaneously boost anti-influenza immunity and induce production of therapeutically active anti-Aβ antibodies.
Conclusion
This strategy might be beneficial for treating Alzheimer's disease patients and preventing its development in pre-symptomatic individuals while boosting immunity against influenza.
Supporting Evidence
- Chimeric flu viruses expressing Aβ1-10 induced stronger antibody responses than those expressing Aβ1-7.
- Immunization with WSN-Aβ1-10 resulted in high titers of anti-Aβ antibodies.
- Anti-Aβ antibodies generated by the vaccine bound to Aβ plaques in human brain tissue.
- Vaccination with WSN-Aβ1-10 improved cell viability in neurotoxicity assays.
- Both anti-Aβ and anti-influenza antibodies were produced in response to the vaccine.
Takeaway
Researchers created a new vaccine that helps fight both the flu and Alzheimer's disease by teaching the body to make special antibodies.
Methodology
Mice were immunized with chimeric influenza viruses expressing Aβ peptides and their immune responses were measured.
Potential Biases
Potential bias in the interpretation of results due to the small sample size and animal model used.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female, 5-6 week-old C57Bl/6 mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website